Should I Buy OXBR? OXBR 2026 Analysis

Should You Buy Oxbridge Re Holdings Ltd (OXBR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.020

1 Day change

52 Week Range

5.810

Analysis Updated At

2026/01/30

OXBR is not a good buy right now. The stock is in a clear downtrend (bearish moving-average stack and worsening MACD momentum), fundamentals are deteriorating (revenue and earnings down YoY with a larger net loss), and there are no proprietary buy signals (AI Stock Picker/SwingMax) to justify an impatient entry. Stay on the sidelines until trend/momentum improves or a clear catalyst changes the setup.

Technical Analysis

Price/Trend: Bearish trend structure with SMA_200 > SMA_20 > SMA_5, indicating sustained downside pressure. Momentum: MACD histogram at -0.0242 and negatively expanding, signaling strengthening bearish momentum. RSI: RSI_6 at 20.984 suggests heavily oversold conditions (despite the provided label), which can allow for short-lived bounces, but oversold alone is not a buy signal while MACD is still deteriorating. Levels: Pre-market ~1.02 is below S1 (1.045) and below pivot (1.152), meaning prior support has likely turned into resistance. Next support is S2 at 0.979; resistance zones to reclaim are 1.045–1.152, then 1.259. Pattern-based forward view: Similar-pattern stats imply mild upside next day/week (+0.97% / +1.04%) but a negative bias over the next month (-5.75%). Intellectia Proprietary Trading Signals - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Positive Catalysts

can fuel a reflex bounce if buyers step in around 0.98–1.
Upcoming earnings: Q earnings scheduled for 2026-02-12 (after hours) could act as a volatility catalyst.

Neutral/Negative Catalysts

with bearish momentum expanding (MACD histogram worsening).
and trading under pivot (1.
increases risk of further weakness toward S2 (0.979).

Financial Performance

Latest quarter: 2025/Q3. Revenue: $634K, down 3.50% YoY (soft top-line trend). Net income: -$187K, down 65.37% YoY (loss widened materially). EPS: -$0.02, down 77.78% YoY (profitability deterioration). Overall: The quarter shows weakening growth/profitability, which does not support a conviction buy during a technical downtrend.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating/price target change data was provided, suggesting limited or no meaningful recent Wall Street coverage. Wall Street pros/cons view (based on available data): Pros are hard to identify without coverage; the main potential 'pro' is a short-term oversold bounce. Cons dominate: worsening earnings profile and a clearly bearish technical trend with no confirmed buy signals.

Analyst Rating

Wall Street analysts forecast OXBR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OXBR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1.020

Low

Averages

High